Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Edelman

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Diabetes Care|September 28, 2006
A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetesSteve Edelman, Satish Garg, Juan Frias, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 25, 2020
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study DesignTadej Battelino, Zsolt Bosnyak, Thomas Danne, et al.
Plos One|November 14, 2013
Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessmentGhanashyam Sarikonda, Jeremy Pettus, Sowbarnika Sachithanantham, et al.
The American Journal of Managed Care|January 9, 2026
HEDIS glycemic goal achieved using control-IQ TechnologyBimal V Patel, Sharon M Wang, Laurel H Messer, et al.
Journal of Autoimmunity|January 7, 2014
CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetesGhanashyam Sarikonda, Jeremy Pettus, Sonal Phatak, et al.
Cardiovascular Diabetology|March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Diabetes Care|September 28, 2006
A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetesSteve Edelman, Satish Garg, Juan Frias, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 25, 2020
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study DesignTadej Battelino, Zsolt Bosnyak, Thomas Danne, et al.
Plos One|November 14, 2013
Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessmentGhanashyam Sarikonda, Jeremy Pettus, Sowbarnika Sachithanantham, et al.
The American Journal of Managed Care|January 9, 2026
HEDIS glycemic goal achieved using control-IQ TechnologyBimal V Patel, Sharon M Wang, Laurel H Messer, et al.
Journal of Autoimmunity|January 7, 2014
CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetesGhanashyam Sarikonda, Jeremy Pettus, Sonal Phatak, et al.
Cardiovascular Diabetology|March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Pageof 2